Guggenheim Upgrades Cardinal Health (CAH) to Buy

Guggenheim analyst Glen Santangelo upgraded Cardinal Health (NYSE: CAH) from Neutral to Buy with a price target of $52.00 (from $50.00).

• Says stabilizing fundamentals and low expectations offers a skewed risk/reward.

For an analyst ratings summary and ratings history on Cardinal Health click here. For more ratings news on Cardinal Health click here.

Shares of Cardinal Health closed at $43.48 yesterday.

You May Also Be Interested In

• Lowe's (LOW) PT Lowered to $275 at Guggenheim
• HomeTrust Bancshares (HTB) PT Raised to $57 at Stephens
• Freedom Broker Upgrades Taylor Devices, Inc. (TAYD) to Buy